| 5.1 Resolution of ear discharge (1 to 2 weeks) |
3 |
702 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.14 [0.97, 1.35] |
| 5.1.1 Levofloxacin versus co‐amoxiclav |
1 |
22 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.25 [0.68, 2.28] |
| 5.1.2 Pipemidic acid versus aminobenzylpenicillin |
1 |
428 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.15 [0.93, 1.42] |
| 5.1.3 Norfloxacin versus aminobenzylpenicillin |
1 |
252 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.12 [0.85, 1.48] |
| 5.2 Suspected ototoxicity |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 5.2.1 Dizziness or vertigo |
1 |
22 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.28 [0.01, 6.25] |
| 5.2.2 Tinnitus |
1 |
22 |
Risk Ratio (M‐H, Fixed, 95% CI) |
Not estimable |
